Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Jingfang Granules in Treating Diarrhea-Predominant Irritable Bowel Syndrome With Cold-Dampness Disturbing Spleen Syndrome
NCT07688161Phase 3Not yet recruiting
- Sponsor
- Nanjing First Hospital
- Start
- Jul 2026
- Primary completion
- Jan 2028
- Countries
- 1
01
Overview
A Phase 3 trial of Jingfang Granules in Irritable bowel syndrome with diarrhea (IBS-D), sponsored by Nanjing First Hospital. Planned start Jul 2026; status: not yet recruiting.
02
Drugs
Jingfang Granules
03
Conditions
Irritable bowel syndrome with diarrhea (IBS-D)
Beyond the preview
Go deeper on NCT07688161.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07688161.